It’s a great day for investors, as stock prices are rising and the AEX index is at its highest point in over 18 years.
The midcap index is even at an all-time high. The U.S. economy is still doing well, given the fact that many more jobs were created than expected.
Business figures are not disappointing, the economy is not doing as badly as feared and yet the Fed, the U.S. central bank, has lowered interest rates.
Moreover, there is “hope for a trade deal between the U.S. and China, while a Brexit without a deal is also briefly off the table,” explains stock market commentator Durk Veenstra.
Last Friday, the broad American S&P 500 index and technology index Nasdaq already closed at its highest-ever final score.
The AEX index was just above 587 points and this is more than the highest level of 586,32 points achieved at the end of July.
The highest end of the year so far is somewhat lower: at 583.83 points, which was reached on Oct. 25. If we close around the current level, then the AEX will also be the highest end of the year.
Last week the AEX also seemed to be a little above the previous level, but that didn’t work out in the end.
The mid-cap index of medium-sized listed companies is also doing well. It is above 881 points and that is actually the highest point ever. The previous high was 878.97 points, which was reached last Monday.
There is also a party on the U.S. stock exchanges. The American Dow Jones index is rising to its highest level ever. The broad S&P 500 index and the Nasdaq, which contains many technology stocks, are also on the rise.
The last two set an all-time high last Friday, but are breaking those records today.
The AEX index is not yet at its highest point ever, which was reached on Sept. 4, 2000, when the AEX ended at 701.56 points.
One day later, intraday even reached a score of 703.18 points. We are now 20% below that.
AEX calculated differently from S&P
The fact that the Amsterdam AEX index has not yet reached the highest level ever is mainly due to the fact that the AEX index differs from the S&P 500, which is a reinvestment index.
This means that the calculation is based on the assumption that dividends received are reinvested in shares from that index. This is not the case with the AEX.
The Nasdaq is not a reinvestment index either, but profits from technology funds have risen faster than those of other listed companies.
On the Dow Jones index, there’s a lot to be said about, that’s how you can describe it as a worthless index.
A striking feature of the AEX is that only four listed companies are so large that they determine about half of the index. These are Shell, Unilever, ING, and ASML.
If you are interested in finding more reliable information about stock exchanges and stock markets, there are several business applications that will keep you up to date. Take a look at this business application and you will always be informed about the latest news in this field.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Please review our disclaimer for more information.
First published in RTL Nieuws, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us. Please review our disclaimer for more information.
Another biotech gem from Switzerland secures growth capital
A biotech spin-off from the Universities of Zurich and Basel has received new funds from a financing round with renowned...
Industrial espionage costs German companies $229.4 billion
According to the Federation of German Industries (BDI), data theft, industrial espionage and sabotage have cost German companies $229.1 billion...
French Real Estate Crowdfunding grew by 80% in 2019
Real estate crowdfunding is a new way for investors to raise money for their affairs. Crowdfunding for real estate brings...
Growing Capacity: Why Smart Expansion Is Key To Success Among Cannabis Growers
Soaring demand is driving the cannabis market to new highs, as thousands of under served clients can finally obtain their...
Investors react to the Sanofi-Regeneron collaboration
Regeneron Pharmaceuticals Inc shares rebounded as investors found out about collaboration partner Sanofi SA’s liquidation of its Regeneron stake. The...
- Crypto6 days ago
Swiss licensed crypto bank is expanding into 9 new markets
- Biotech7 days ago
Geman Biotech Stocks: Mologen (MGNK) goes insolvent while MorphoSys (MOR) strengthens its position
- Business4 days ago
Where Social Media is Headed in 2020
- Cannabis7 days ago
Brazilian health authority approves registration of cannabis medicines